FDA approves once-daily Idvynso tablet for treating HIV

FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA

FDA Approves New Once-Daily HIV Treatment Medication

Archyde The U.S. Food and Drug Administration (FDA) has approved a new once-daily medication for the treatment of HIV-1, aiming to simplify antiretroviral therapy (ART). Alongside this medical advancement, health experts ... Read More The post FDA Approves New Once-Daily HIV Treatment Medication appeared first on Archyde.